Literature DB >> 1876514

Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients.

P Labrune1, P Huguet, M Odievre.   

Abstract

Cardiac examinations were performed on 18 patients with glycogen-storage disease (GSD) type III. Clinical examination was always normal and the electrocardiograms revealed nonspecific data. Similarly, serum muscular enzyme activities were not useful in indicating the presence of cardiomyopathy. Echocardiographic evidence of myocardiopathy was found in five of the 16 children studied (mean age, 9.5 years). Echocardiographic parameters remained stable during the follow-up period (at least 3 years). The other 11 children had no echocardiographic evidence of cardiomyopathy. No relationship was found between peripheral myopathy and cardiomyopathy. All patients with GSD type III should be regularly investigated by echocardiography in respect of their cardiac muscle status.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876514     DOI: 10.1007/BF02238523

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  [Glycogenosis type III myocardiopathy].

Authors:  A M Rossignol; M Meyer; B Rossignol; M P Palcoux; E J Raynaud; M Bost
Journal:  Arch Fr Pediatr       Date:  1979-03

2.  [Long-term course of hepatic glycogenosis. A retrospective study of 76 cases].

Authors:  L de Parscau; P Guibaud; P Labrune; M Odièvre
Journal:  Arch Fr Pediatr       Date:  1988-11

3.  [Determination of blood level of muscle enzymes in glycogenoses with liver involvement: a diagnostic criterion].

Authors:  P Labrune; J Chalas; J P Pignon; C Hennion; M Odièvre
Journal:  Ann Pediatr (Paris)       Date:  1989-05

4.  Severe cardiopathy in branching enzyme deficiency.

Authors:  S Servidei; R E Riepe; C Langston; L Y Tani; J T Bricker; N Crisp-Lindgren; H Travers; D Armstrong; S DiMauro
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

5.  Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency.

Authors:  S Servidei; L A Metlay; J Chodosh; S DiMauro
Journal:  J Pediatr       Date:  1988-07       Impact factor: 4.406

6.  The subgroups of type 3 glycogenosis.

Authors:  F Van Hoof; H G Hers
Journal:  Eur J Biochem       Date:  1967-10

7.  Metabolic myopathies.

Authors:  S DiMauro; A F Miranda; S Sakoda; E A Schon; S Servidei; S Shanske; M Zeviani
Journal:  Am J Med Genet       Date:  1986-12

8.  Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy.

Authors:  L J Olson; G S Reeder; K L Noller; W D Edwards; R R Howell; V V Michels
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

9.  Neuromuscular involvement in glycogen storage disease type III.

Authors:  S W Moses; N Gadoth; N Bashan; E Ben-David; A Slonim; K L Wanderman
Journal:  Acta Paediatr Scand       Date:  1986-03

Review 10.  Disorders of glycogen metabolism of muscle.

Authors:  S Servidei; S DiMauro
Journal:  Neurol Clin       Date:  1989-02       Impact factor: 3.806

  10 in total
  9 in total

1.  Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.

Authors:  P Lee; M Burch; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Authors:  Christiaan P Sentner; Kadir Caliskan; Wim B Vletter; G Peter A Smit
Journal:  JIMD Rep       Date:  2011-12-13

Review 3.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  A New Perspective on the Quality of Life of Children with Glycogen Storage Diseases.

Authors:  Gihan Ahmed Sobhy; Mortada El-Shabrawi; Heba Safar
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-07-06

5.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

6.  Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Authors:  A I Dagli; R T Zori; H McCune; T Ivsic; M K Maisenbacher; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2009-03-30       Impact factor: 4.982

Review 7.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

8.  Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.

Authors:  Shawyntee M Vertilus; Stephanie L Austin; Kimberly S Foster; Keri E Boyette; Deeksha S Bali; Jennifer S Li; Priya S Kishnani; Stephanie Burns Wechsler
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

9.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.